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BLOOD LIPIDS AND CAROTID PLAQUES
Marjan Zaletel and Bojana Ævan
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SUMMARY · Increased lipids in the blood could be associated with an increased lipid core of ath-
erosclerotic plaque and plaque echolucency on the B-mode image. The hypothesis that plasma levels
of blood lipids predict the echolucency of carotid atherosclerotic plaques on B-mode imaging was
tested. A total of 237 outpatients, mean age 62.9±10.2 years, were enrolled in the study. There were
189 symptomatic and 48 asymptomatic patients. All of them underwent duplex sonography of ca-
rotid arteries and lipidogram in the last year, and had plaques in common or internal carotid arteries.
Other risk factors, i.e. arterial hypertension, diabetes mellitus, aging and gender, were also evaluated.
In the model of logistic regression, the type of plaque (hypoechogenic, echogenic) was introduced as
a dependent variable, with LDL, HDL and triglycerides as independent variables. The model fitted
the data moderately well (r2=0.19, p<0.001). LDL and HDL appeared to be significant predictors
(p<0.01).The association of plaque type with arterial hypertension, diabetes mellitus, aging and gender
was tested by logistic regression. The model fitted the data moderately well (r2=0.24, p<0.001). Ar-
terial hypertension and age were significant (p<0.01) predictors for echogenic plaques, whereas ciga-
rette smoking was indicative of hypoechogenic plaques (p=0.01). In conclusion, LDL and HDL ap-
peared to be associated with hypoechogenic plaques. LDL showed positive, and HDL negative as-
sociation. Among other risk factors, aging and arterial hypertension showed positive association with
echogenic plaques, whereas cigarette smoking showed positive association with hypoechogenic plaques.
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Introduction
Atherosclerosis is an inflammatory disease1.The most
common risk factors for carotid atherosclerosis are hyper-
tension, hyperlipidemia, and cigarette smoking2.The pre-
dominating mechanism is macrophage accumulation in
atherosclerotic plaques caused by an accumulation of low-
density lipoprotein (LDL). Macrophages at the sites of
ongoing inflammation in advanced atherosclerotic plaques
may precipitate plaque rupture, leading to acute clinical
events such as myocardial infarction3. Oxidative modifi-
cation of LDL is believed to play a major role in athero-
genesis because LDL is converted to an atherogenic form
that is rapidly taken up by macrophages mediated via the
scavenger receptor4. Since these pathways are not feed-
back controlled, lipids may be taken up excessively. These
lipids are deposited within the macrophages, which
thereby develop into lipid-laden foam cells5. On the other
hand, plasma high density lipoprotein (HDL) levels show
an inverse relationship to atherogenesis. HDL removes
cholesterol from peripheral cells such as arterial wall mac-
rophages. Particular subfractions of HDL, such as the pre-
ß-HDL fraction, may be especially efficient in mediating
cholesterol removal from peripheral cells6. The disruption
of blood flow is thought to be a result of embolization
arising from degenerative breakdown or thrombotic oc-
clusion of complex plaques in the extracranial vessel ar-
eas that are readily accessible to ultrasound imaging. Re-
cent studies support the notion that not only the degree
of stenosis but also the morphology of the carotid artery
plaque and surface characteristics such as ulceration may
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be of pathogenic importance7. With the use of high-reso-
lution ultrasound B-mode imaging, carotid plaques evalu-
ated as only weakly reflecting the ultrasound beam
(echolucent) have been associated with a higher risk of
neurologic events than are plaques strongly reflecting the
ultrasound signal (echogenic)8.
Cholesterol in plasma is distributed among four lipo-
protein fractions: HDL, LDL, IDL, and VLDL, in or-
der of increasing particle diameter. In the postprandial
state, chylomicrons and chylomicron remnants may also
be present in the plasma. Hypercholesterolemia is an im-
portant causal risk factor for atherosclerosis9. LDL is rec-
ognized as the major atherogenic lipoprotein. Accumu-
lation of lipoproteins in the intima is dependent on the
balance between the rates at which they enter and leave
the arterial wall, and the rate at which they are degraded
within it. Studies in humans, rabbits and pigs suggest that
the influx of lipoproteins into the intima increases directly
with the increasing lipoprotein concentration in the
plasma10. Hence, the increased concentration of LDL and
decreased concentration of HDL lipids in the blood could
be associated with an increased volume of lipid core of
atherosclerotic plaque and with an increased echolucency
of the plaque on B-mode image.
In the present study, we tested the hypothesis that el-
evated plasma levels of blood lipids in the fasting or post-
prandial state predict echolucency of the carotid athero-
sclerotic plaques on ultrasound B-mode imaging.
Subjects and Methods
Patients
A total of 237 outpatients (171 men and 66 women,
mean age 62.9±10.2 years) were enrolled in the study, 189
of them symptomatic and 48 asymptomatic. Of them, 116
(61%) patients had suffered a stroke, while 69 (36%) pa-
tients had experienced transient ischemic attack or amau-
rosis fugax. All of them underwent color-coded duplex
sonography and power sonography examination of carotid
arteries during the past year. The criteria for entry in the
study were the presence of plaques in common or inter-
nal carotid arteries and no use of lipid-lowering medica-
tions. Age, sex, height, and weight were recorded. Car-
diovascular risk factors were noted: hypertension (current
and previous use of antihypertensive drugs and/or blood
pressure >160/95 mm Hg) and diabetes mellitus (therapy
with oral hypoglycemic agents or insulin, with an antidia-
betic diet) as well as cigarette smoking. All of the patients
had to have four fraction lipidograms including total cho-
lesterol, LDL, HDL and triglycerides.
Ultrasonography
Carotid arteries were scanned with an Aloca 5500
color-coded duplex ultrasound device with a 10-MHz lin-
ear array transducer. High-resolution B-mode and color
Doppler images of the plaques from the anterior, lateral
and cross-sectional scan plane were evaluated on-line by
use of the widely accepted criteria. The ultrasound images
were subjectively graded according to the relative contri-
bution of echogenic (high-intensity) and echolucent (low-
intensity) material, using the classification of European
Carotid Plaque Study Group11. The plaques were divided
as follows: type I, predominantly echolucent plaque with
a thin echogenic cap; type II, substantially echolucent le-
sions with small areas of echogenicity; type III, predomi-
nantly echogenic lesions with small areas of echolucency;
type IV, uniformly echogenic lesions (equivalent to homo-
geneous); and type V, unclassified plaques, mainly
calcinated.
Statistical analysis
All values of blood lipids were expressed as mean ± SD.
Multiple linear regression was used to test the association
between cholesterol and LDL, HDL and triglycerides.
Logistic regression was used to evaluate the association
between the hypoechogenic and echogenic plaques and
blood lipids as well as risk factors. The mean difference
was considered significant at a level of p<0.05.
Results
Initially, carotid plaques were divided into five classes.
For the purpose of further analysis, the plaques were re-
classified into two groups according to the contribution
of echogenicity or echolucency. Type I (Fig. 1) and type
II represented hypoechogenic group, while types III, IV
and V were pooled in echogenic group. Preliminary analy-
sis included testing of association of blood lipoproteins
with cholesterol levels. In the model of linear regression,
cholesterol was introduced as an independent variable,
while LDL, HDL and triglycerides were used as depen-
dent variables. The model fitted the data very well
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(r2=0.73, p<0.001), and it was significant. LDL, HDL and
triglycerides appeared to be significant in the model.
Thus, we tested the reliability of the data. The results are
shown in Table 1.
The association between the type of plaque with
HDL, LDL and triglycerides is presented in Table 2. In
the model of logistic regression, the type of plaque (0 =
hypoechogenic, 1 = echocgenic) was introduced as a de-
pendent variable. HDL, LDL and triglycerides were in-
dependent variables. The model fitted the data moderately
well (Cox & Snell = 0.19, p<0.001), and it was significant.
HDL was positively and significantly (p<0.01) associated
with echogenic plaques. It showed the strongest associa-
tion. In addition, LDL appeared to be significantly
(p<0.01) and positively associated with hypoechogenic
plaques. Triglycerides did not reach the level of signifi-
cance.
Logistic regression was used to evaluate the associa-
tion between the well recognized risk factors and type of
plaque (Table 3). The type of plaque was introduced as a
dependent variable (0 = hypoechogenic, 1 = echogenic),
while diabetes mellitus, arterial hypertension, age, gender
and cigarette smoking served as independent variables.
The model appeared to be moderately significant (Cox &
Snell = 0.24, p<0.001). Arterial hypertension and age
(p<0.01) were significantly and positively associated with
echogenic plaque, while cigarette smoking was positively
associated with hypoechogenic plaques (p=0.01). Diabe-
tes mellitus and gender did not appear to be significant
in the model.
Fig. 1. A hypoechogenic plaque
Table 1. Cholesterol association with LDL, HDL and triglycerides
Nonstandardized Standardized t Significance
coefficients coefficient
B SE Beta
LDL 0.949 0.037 0.886 25.736 0.000
HDL 0.254 0.119 0.071 02.140 0.033
TG 0.241 0.038 0.217 06.315 0.000
SE=standard error; HDL=high-density lipoprotein; LDL=low-density lipoprotein;
TG=triglycerides
Table 2. Association between plaque type and blood lipids
B SE Wald df Significance Exp (B)
HDL 01.482 0.496 08.917 1 0.003 4.404
LDL -0.818 0.169 23.531 1 0.000 0.441
TG -0.185 0.157 01.384 1 0.239 0.831
SE=standard error; HDL=high-density lipoprotein; LDL=low-density lipoprotein;
TG=triglycerides
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Discussion
Echolucency on the subjective evaluation of carotid
atherosclerotic plaques has previously been associated with
an increased incidence of neurologic symptoms12, and an
increased incidence of asymptomatic brain infarction on
CT scans13. One important new observation in the
present study was that elevated plasma levels of LDL in
the fasting or postprandial state predicted the appearance
of hypoechogenic carotid atherosclerotic plaques. Studies
have shown that LDL is the best lipid predictor for the
extent of atherosclerosis14. Particularly elevated rates of
the occurrence of arterial hypertension and hyperlipidemia
were detected in younger individuals exposed to chronic
stress15.
A number of studies used ultrasound B-mode to mea-
sure wall thickness of the extracranial part of carotid arter-
ies (intima-media thickness, or IMT) as an indicator of
atherosclerotic diseases. There is evidence that an increase
in IMT is linked with different risk factors for atheroscle-
rosis, such as age, systolic blood pressure, a history of coro-
nary heart disease, diabetes mellitus, levels of LDL, and
smoking habits16. However, none of the previous studies
evaluated LDL as a risk factor for hypoechogenic plaques.
Furthermore, it has been suggested that plasma LDL re-
duction causes reduction in the lipid content of plaques with
a lipid-rich core and thin fibrous cap, thereby reducing the
likelihood that these otherwise vulnerable plaques will rup-
ture, causing either an embolism or thrombosis leading to
infarction. Double-blind intervention trials have demon-
strated that reduction in plasma LDL levels leads to reduced
progression or even regression of atherosclerotic plaques in
coronary arteries17. The biologically important modifica-
tion of LDL is oxidation leading to the formation of oxi-
dized LDL (OX-LDL). Recently, there has been increas-
ing evidence that OX-LDL may play a fundamental role
in atherosclerosis18. Increased levels of OX-LDL are found
in atherosclerotic plaques19.
A search for determinants in the blood for hypoecho-
genic plaques suggests that triglyceride-rich lipoproteins
in particular seem to predict for echolucent plaques20. In
our study, we did not succeed in confirming this finding.
Like LDL, triglyceride-rich lipoproteins can transfer from
plasma into the arterial intima where such particles ap-
pear to be retained selectively21. It is important to note that
triglyceride-rich lipoproteins of the size of chylomicrons
(>75 nm) do not seem to enter the intima, whereas smaller
triglyceride-rich lipoproteins are able to enter it22. In con-
trast to LDL, triglyceride-rich lipoproteins can without
prior modification be taken up directly by macrophages
to produce foam cells23.
Other studies have shown that low levels of HDL
cholesterol are associated with an increased risk of hav-
ing echolucent, rupture-prone atherosclerotic plaques24.
Our study also showed strong association of HDL with
the type of plaque. Lower levels appeared to be associated
with hypoechogenic plaques, and higher levels of HDL
with echogenic plaques. Multiple regression analysis
showed age to be directly and HDL cholesterol indirectly
related to IMT (p<0.05)25. An underlying component of
the inverse relationship between the plasma HDL levels
and risk of cardiovascular disease is the ability of HDL
to protect against or even to reverse LDL oxidation. Also,
HDL protects against the development of atherosclero-
sis through its role in reverse cholesterol transport24, thus
increasing the level of HDL, decreasing the plaque lipid
content, and promoting plaque organization.
Among risk factors we found a significant positive
association of arterial hypertension and age with echo-
genic plaque, and negative association with hypoecho-
genic plaque. Hypertension is a risk factor for the devel-
opment of atherosclerosis, although the mechanisms have
not been well elucidated. The cardinal pathologic features
of atherosclerotic lesion development include the presence
of monocytes/macrophages and T cells, their localization
in the large conduit or elastic arteries in the areas of low
Table 3. Type of plaque association with risk factors
Risk factor B SE Wald df Significance Exp (B)
Diabetes mellitus 00.328 0.296 01.222 1 00.269 1.388
Arterial hypertension 00.918 0.286 10.295 1 00.001 2.504
Age 00.108 0.023 21.646 1 00.000 1.114
Smoking -0.749 0.292 06.568 1 0.01 0.473
Gender 00.036 0.287 00.016 1 00.901 1.036
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shear stress, proliferation and migration to the intima of
medial smooth muscle cells, deposition of increased
amounts of connective tissue, and neovascularization26.
Hypertensive arteries are thickened, and there may be an
increased smooth muscle cell mass and/or cell number and
increased deposition of connective tissue27. Noninvasively,
it has been shown that carotid intima-media thickness
correlates with blood pressure and is predictive of future
cardiovascular events, and can be used as an endpoint in
intervention trials. Placebo-controlled studies have shown
the beneficial effects of calcium antagonists and beta-
blockers, and contradictory responses with angiotensin
converting enzyme inhibitors28. The mechanistic data
showing that monocyte recruitment mechanisms involve
redox-sensitive steps have been previously summarized
and would lead one to predict that hypertension per se,
even in the absence of the metabolic stress of hyperlipi-
demia, might be associated with increased recruitment of
mononuclear cells into the arterial wall. In animal mod-
els, hypertension is associated with leukocyte adhesion,
macrophage accumulation, smooth muscle cell migration
and proliferation, and intimal thickening28. Lipid accu-
mulation in foam cells and the formation of atheroscle-
rotic plaque are generally not observed if plasma lipopro-
teins are low29. This could explain our association of ar-
terial hypertension with more dense-echogenic plaques.
By analogy with previous reports, age turned out to be
the strongest risk predictor of atherosclerosis. This may
well be the expression of the intrinsic effects of aging but
more likely reflects the cumulative component in the ex-
posure to various risk factors. This indicates that the as-
sociation of aging with echogenic plaques primarily re-
flects an advance of the atherosclerotic process30.
Smoking doubles the risk of myocardial infarction and
ischemic stroke31. It is known that cigarette smoking is
associated with increased lipid peroxidation and therefore
increased OX-LDL, which can lead to increased plaque
lipid content and to the formation of hypoechogenic
plaques32. Thus, cigarette smoking promotes the athero-
sclerotic process. However, it also affects other elements
involved in the atherosclerotic process such as endothe-
lium, increases vascular tone and platelet activation, and
decreases the levels of free protein S33.
Our study showed the association of LDL and HDL
with hypoechogenic plaques. LDL showed positive, and
HDL negative association. We did not establish an asso-
ciation between triglycerides and hypoechogenic plaques.
Among other risk factors, aging and arterial hypertension
showed positive association with echogenic plaques. Ciga-
rette smoking showed positive association with hypoecho-
genic plaques. Diabetes mellitus and gender did not cor-
relate with any type of plaques.
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Saæetak
LIPIDI U KRVI I KAROTIDNI PLAK
M. Zaletel i B. Ævan
Povi¹eni lipidi u krvi mogli bi biti udruæeni s poveÊanom lipidnom jezgrom aterosklerotskog plaka i eholucencijom plaka
na prikazu u B-modu. Ispitana je pretpostavka da plazmatske razine lipida u krvi predskazuju eholucenciju karotidnih
aterosklerotskih plakova na prikazu u B-modu. U studiju je bilo ukljuËeno ukupno 237 ambulantnih bolesnika srednje dobi
od 62,9±10,2 godina, 189 od njih simptomatskih i 48 asimptomatskih. Svi su bolesnici u protekloj godini podvrgnuti pretrazi
karotidnih arterija pomoÊu dupleks sonografije. Svi su bolesnici imali plakove u skupnoj ili unutarnjoj karotidnoj arteriji i u
svih je uËinjen lipidogram. Procjenjivani su i drugi riziËni Ëimbenici kao ¹to su arterijska hipertenzija, ¹eÊerna bolest, starenje
i spol. U model logistiËne regresije uvedena je vrst plaka (hipoehogeni ili ehogeni) kao zavisna varijabla, uz LDL, HDL i
trigliceride kao nezavisne varijable. Model je umjereno dobro odgovarao podacima (r2=0,19; p<0,001). LDL i HDL pokazali
su se znaËajnim predskazateljima (p<0,01). Udruæenost vrste plaka s arterijskom hipertenzijom, ¹eÊernom bole¹Êu, starenjem
i spolom ispitana je logistiËnom regresijom. Model je umjereno odgovarao podacima (r2=0,24; p<0,001). Arterijska hipertenzija
i starosna dob bile su znaËajni (p<0,01) predskazatelji ehogenih plakova, dok je pu¹enje ukazivalo na hipoehogene plakove
(p=0,01). ZakljuËeno je kako su LDL and HDL udruæeni s hipoehogenim plakovima. LDL je pokazao pozitivnu, a HDL
negativnu udruæenost. Meðu ostalim Ëimbenicima rizika starenje i arterijska hipertenzija pokazali su pozitivnu udruæenost s
ehogenim plakovima, a pu¹enje pozitivnu udruæenost s hipoehogenim plakovima.
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